BioSig Technologies (NASDAQ:BSGM) Shares Down 8.4%

BioSig Technologies, Inc. (NASDAQ:BSGM)’s share price traded down 8.4% during mid-day trading on Friday . The company traded as low as $1.35 and last traded at $1.41. 199,537 shares traded hands during mid-day trading, a decline of 80% from the average session volume of 983,634 shares. The stock had previously closed at $1.54.

BioSig Technologies Stock Performance

The company’s 50-day moving average price is $0.78 and its 200 day moving average price is $2.62. The stock has a market capitalization of $15.79 million, a PE ratio of -0.29 and a beta of 1.21.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Advisor Resource Council raised its holdings in BioSig Technologies by 19.6% in the third quarter. Advisor Resource Council now owns 1,077,906 shares of the company’s stock worth $527,000 after buying an additional 176,700 shares during the last quarter. PFG Investments LLC raised its holdings in BioSig Technologies by 79.3% in the third quarter. PFG Investments LLC now owns 143,600 shares of the company’s stock worth $70,000 after buying an additional 63,500 shares during the last quarter. Smith Moore & CO. raised its holdings in BioSig Technologies by 31.9% in the first quarter. Smith Moore & CO. now owns 123,575 shares of the company’s stock worth $141,000 after buying an additional 29,910 shares during the last quarter. Northern Trust Corp raised its holdings in BioSig Technologies by 24.8% in the second quarter. Northern Trust Corp now owns 110,859 shares of the company’s stock worth $139,000 after buying an additional 21,995 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in BioSig Technologies by 6.5% in the fourth quarter. Geode Capital Management LLC now owns 269,208 shares of the company’s stock worth $113,000 after buying an additional 16,405 shares during the last quarter. 7.16% of the stock is owned by hedge funds and other institutional investors.

About BioSig Technologies

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.